# Live Birth After Additional Tubal Flushing With Oil-based Contrast Versus no Additional Flushing:

> **NCT04379973** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Dafne Balemans** · enrollment: 736 (estimated)

## Conditions studied

- Infertility, Female

## Interventions

- **DRUG:** Lipiodol Ultra Fluide®

## Key facts

- **NCT ID:** NCT04379973
- **Lead sponsor:** Dafne Balemans
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-25
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 736 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04379973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04379973, "Live Birth After Additional Tubal Flushing With Oil-based Contrast Versus no Additional Flushing:". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT04379973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*